Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma

Annals of Oncology

Volumn 21, Issue 7, 2010, Pages 1563-1565

  Kodaira, M ^a   Takahashi, S ^a   Takeuchi, K ^b   Yuasa, T ^a   Saotome, T ^a   Yonese, J ^b   Fukui, I ^b   Hatake, K ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; SORAFENIB; STEROID; SUNITINIB;

ADULT; AGED; CASE REPORT; DESQUAMATION; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; FATIGUE; FEMALE; HAND FOOT SYNDROME; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN TISSUE; KERATINOCYTE; KIDNEY CARCINOMA; LETTER; LUNG METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MEASLES; METASTASIS POTENTIAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SKIN BIOPSY; STOMATITIS;

EID: 77954294489     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq299     Document Type: Letter

References (8)

1. Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal cell carcinoma. N Eng J Med 2007; 356: 125-134.
2. Akaza H, Tsukamoto T, Murai M et al. Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma. Jpn J Clin Oncol 2007; 37: 755-762.
3. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
4. MacGrecor JL, Silber DN, Grossman ME et al. Sorafenib induced erythema multiforme. J Am Acad Dermatol 2007; 56: 527-528.
5. Bilac C, Muezzinoglu T, Ermertcan AT et al. Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma. Cutan Ocul Toxicol 2009; 28: 90-92.
6. Feltes RA, Feito Rodriguez M, Gonzalez-Beato MJ. Erythema multiforme induced by sorafenib. Clin Exp Dermatol 2009; 34: e368-e369.
7. Van Erp NP, Eechoute K, van der Veldt AA et al. Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity. J Clin Oncol 2009; 27: 4406-4412.
8. Gandara DR, Kawaguchi T, Crowley J et al. Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. J Clin Oncol 2009; 27: 3540-3546.